Antiglycation activity of melatonin
- 作者: Dontsov A.E.1, Vospelnikova N.D.2, Zack P.P.1, Ostrovsky M.A.1
-
隶属关系:
- Emanuel Institute of Biochemical Physics
- Sechenov First Moscow State Medical University, Ministry of Healthcare of the Russian Federation
- 期: 卷 475, 编号 1 (2017)
- 页面: 283-286
- 栏目: Biochemistry, Biophysics, and Molecular Biology
- URL: https://journals.rcsi.science/1607-6729/article/view/211958
- DOI: https://doi.org/10.1134/S1607672917040111
- ID: 211958
如何引用文章
详细
For the first time, it was found that the hormone melatonin exhibited antiglycation activity in vitro. It was shown that melatonin significantly slowed down the accumulation of fluorescent Schiff adducts formed as a result of BSA modification in the presence of high concentration of fructose. It was noted that, unlike the fructosylation reaction, melatonin did not affect the process of modification of BSA by methylglyoxal. We assume that melatonin is able to inhibit the development of the Maillard reaction but does not affect the process of BSA modification by reactive carbonyls.
作者简介
A. Dontsov
Emanuel Institute of Biochemical Physics
编辑信件的主要联系方式.
Email: adontsovnick@yahoo.com
俄罗斯联邦, Moscow, 119334
N. Vospelnikova
Sechenov First Moscow State Medical University, Ministry of Healthcare of the Russian Federation
Email: adontsovnick@yahoo.com
俄罗斯联邦, Moscow, 119992
P. Zack
Emanuel Institute of Biochemical Physics
Email: adontsovnick@yahoo.com
俄罗斯联邦, Moscow, 119334
M. Ostrovsky
Emanuel Institute of Biochemical Physics
Email: adontsovnick@yahoo.com
俄罗斯联邦, Moscow, 119334
补充文件
